• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » VTT, MSI open Center for Bioengineering in California

VTT, MSI open Center for Bioengineering in California

October 26, 2011
CenterWatch Staff

The VTT Technical Research Centre of Finland and the Molecular Sciences Institute (MSI) have joined forces to establish a new research center in Berkeley, California.

The new VTT/MSI Center for Bioengineering will focus on cutting edge quantitative biology to develop novel strategies for the improved production of bio-based chemicals and proteins in industrial microbes and novel quantitative tools for the detection of toxins, chemicals and biomarkers of disease.

The mission of the research center is to enable the quantitative prediction of the behavior of biological systems. VTT as a member organization of the new institute will provide its frontier knowhow on industrial biotechnology and technological needs for the basic molecular level research carried out at the institute. The aim of the center is to have a positive effect on human health and well-being in addition to the bioeconomy.

“The new center generates basic science which will strengthen VTT’s offering in the field of industrial biotechnology”, says Erkki KM Leppävuori, president & CEO of VTT. “Industrial biotechnology is of high quality at VTT and in Finland. This new opportunity for collaboration is an important bridge between the Californian and European academic as well as industrial network”.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing